Harrow Health Inc (NASDAQ:HROW)

8.55
Delayed Data
As of 4:01pm ET
 +0.05 / +0.59%
Today’s Change
6.00
Today|||52-Week Range
12.99
-1.04%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$229.5M

Company Description

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments. The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.

Contact Information

Harrow Health, Inc.
102 Woodmont Boulevard
Nashville Tennessee 37205
P:(615) 733-4730
Investor Relations:

Employees

Shareholders

Other institutional37.37%
Individual stakeholders22.93%
Mutual fund holders17.11%

Top Executives

Mark L. BaumChairman & Chief Executive Officer
Andrew R. BollChief Financial Officer & Secretary
Larry M. DillahaChief Medical Officer
John P. SaharekPresident-ImprimisRx
Andrew LivingstonChief Innovation Officer